Noxopharm (ASX:NOX) Short Percentage of Float


What is Noxopharm Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ASX:NOX vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, Noxopharm's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Noxopharm Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Noxopharm's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Noxopharm's Short Percentage of Float falls into.


Noxopharm Business Description

Address 60 Linksley Avenue, Glenhaven, NSW, AUS, 2156
Noxopharm Ltd is an Australian clinical-stage drug development company focused on discovering and developing novel treatments for cancer and inflammation, as well as improving mRNA vaccines, based on two preclinical platforms. It is engaged in one segment which is the clinical development in the field of both oncology and non-oncology in the pan-pacific region.